Healthcare professionals

Comparison of doses to OARs

A comparison of doses to OARs in inverse planned IMRT and 3D conformal prostate treatments.


B. Mzenda, P. Peters, J. Pettingell, H. Kerr, K. Walsh, A. Eve, N. McAndrew, M. Robb, S. Razaq, A. Penny


Following the recent Royal College of Radiologists (RCR) recommendations[1, 2] all prostate cancer patients at Cancer Partners UK centres are treated with inverse planned IMRT. This study compares the organ at risk (OAR) doses as well as the PTV dose distributions and irradiated volumes in IMRT and 3D conformal radiotherapy (3DCRT) treatment of prostate carcinoma.

Download the research paper